Toxicity from cancer therapies greater in women: study
Sex differences should be factored in when considering treatment options, researchers suggest
Women experience more symptomatic and haematologic adverse events from cancer treatments than men, especially from immunotherapy, a retrospective analysis has found.
Although between-sex differences in chemotherapy toxicity have been demonstrated in the past, the US researchers said there had been a gap in the literature regarding modern treatments.